Skip to main content
Clinical Trials/CTRI/2024/07/070409
CTRI/2024/07/070409
Not yet recruiting
Phase 2

A Comparative Clinical Study to Evaluate the Combined Effect of Basti and Siravyadha in the Management of Sirajagranthi Vis-a-vis Varicose Veins - NI

Dr N Parameshwari0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr N Parameshwari
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr N Parameshwari

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria
  • Subjects suffering from signs and symptoms of sirajagranthi (varicose veins) pertaining to lower limbs will be selected
  • Subjects of age group between 30\- 50 years will be selected.
  • Subjects with the normal limit of bleeding time and clotting time.
  • Subjects fit for Siravyadha.
  • Subjects fit for Basti.

Exclusion Criteria

  • Exclusion criteria
  • Acute deep vein thrombosis
  • Systemic disorders like DM (HbA1C more than 8\),HTN (more than 140/90mm of Hg)
  • Varicose veins in pregnant women were excluded.
  • Subjects with Anaemia, Hb percentage below 10gms percentage will be excluded.
  • Subjects under anticoagulant medications and bleeding disorders.
  • Arterial insufficiency, acute skin infection at the site of entry.

Outcomes

Primary Outcomes

Not specified

Similar Trials